Login
$CORT
$86.28 -$1.31 (1.5%) Close

$CORT 3 SEC Filings

Filed On Filing
05 Oct 2026 Form 3: Gunn Justin Frederick, See Remarks

Holds 12,191 shares of Common Stock

03 Sep 2026 Form 3: Vieira Roberto Wandenkolk, President, Oncology

Holds 4,068 shares of Common Stock

19 Aug 2021 Form 3: Guyer William, Chief Development Officer

No securities owned

17 Jun 2021 Form 3: Murray Joshua M., Director

No securities owned

03 Mar 2021 Form 3: Mokari Atabak, Chief Financial Officer

No securities owned

02 Dec 2020 Form 3: Cannon Gillian, Director

No securities owned

15 Jul 2020 Form 3: Hunt Hazel, Chief Scientific Officer

Holds 200 shares of Common Stock

15 Jul 2020 Form 3: Lyon Joseph Douglas, Chief Accounting Officer
13 Mar 2020 Form 3: Alton Gregg H, Director

No securities owned

18 Sep 2019 Form 3: Park Kimberly, Director

No securities owned

01 Apr 2019 Form 3: Grauer Andreas, Chief Medical Officer

No securities owned

09 Feb 2018 Form 3: Maduck Sean, See Remarks

Holds 10,024 shares of Common Stock

28 Jun 2016 Form 3: Gala Renee D, Director

No securities owned

01 Oct 2015 Form 3: Fishman Robert S, Chief Medical Officer

No securities owned

22 Jun 2015 Form 3: Swisher Daniel N Jr, Director

Holds 0 shares of No securities are beneficially owned

07 Nov 2012 Form 3: Pullara Samuel J Iii, 10% owner

Holds 29,273 shares of Common Stock

07 Nov 2012 Form 3: Dyckerhoff Stefan A, 10% owner

Holds 29,273 shares of Common Stock

12 Oct 2012 Form 3: Bradbury Daniel, Director

No securities owned

12 Sep 2011 Form 3: Robb Gary Charles, Chief Financial Officer

Holds 1,258 shares of Common Stock

28 Sep 2010 Form 3: Lo Steven, VP Commercial Operations

Holds 0 shares of No securities are beneficially owned

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support